DR. SEAN PATRICK WHALEN M.D. NPI 1043429152

NPI Details

DR. Sean Patrick Whalen, M.D. is a nuclear medicine in New York, NY with 24 years of experience. The provider is a nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone DR. Sean Patrick Whalen, M.D. NPI is 1043429152. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CALIFORNIA, IRVINE, CALIFORNIA COLLEGE OF MEDICINE
Graduation Year:2002

The provider's business location address is:

622 W 168TH ST
NEW YORK, NY
ZIP 10032-720
Phone: (212) 305-9729

The NPI 1043429152 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg (HCPCS:J7328)
• Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg (HCPCS:J7332)
• Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg (HCPCS:J7322)
• Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
• Limited ultrasound scan of joint or other extremity structure lacking blood vessels (HCPCS:76882)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose (HCPCS:J7324)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Complete ultrasound scan of joint (HCPCS:76881)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)

The enumeration date for this NPI number is 5/22/2007 and was last updated on 11/5/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: